| 000 | 03213nam a22003735i 4500 | ||
|---|---|---|---|
| 999 |
_c80343 _d80343 _x1 |
||
| 001 | 80343 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040301.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 141016s2014 xxk| s |||| 0|eng d | ||
| 020 | _a9781907673887 | ||
| 024 | 7 |
_a10.1007/978-1-907673-88-7 _2doi |
|
| 040 | _dES-MaUEC | ||
| 050 | 4 |
_aRC382 _b.M378 2014 |
|
| 100 | 1 |
_aMartínez Martín, Pablo _915123 |
|
| 245 | 1 | 0 |
_aGuide to Assessment Scales in Parkinson's Disease _cby Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz, Kallol Ray Chaudhuri |
| 260 |
_aTarporley _bSpringer International Publishing _c2014 |
||
| 300 |
_a1 recurso en línea (VI, 96 p.) _b15 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _aIntroduction -- Multi-domain scales -- Global severity assessments -- Movement disorders and disability scales -- Comprehensive non-motor symptoms assessments -- Non-motor disorders scales -- Mental aspects scales (cognition and neuropsychiatric symptoms) -- Quality of life scales. | |
| 520 | _aThis Guide assesses the key clinimetric attributes in the assessment of Parkinson's Disease (PD), with the intention to offer rapid and pragmatic information on the most relevant scales used in PD. Parkinson's Disease affects approximately 4 million people globally and is most commonly seen in people over the age of 50. The disease is a progressive disorder of the nervous system, and presents a number of movement and cognitive symptoms, thereby greatly affecting a patients quality of life. The use of scales for assessment in neurological disorders such as PD arises from the need to quantify disorders and states (such constructs as disability, symptoms, quality of life). Assessment scales are often categorised into two categories: generic (i.e. those scales usable in any health condition), and specific (i.e. scales developed for exclusive use in PD). They can have a variety of components: single-item and multi-item or composite scale; unidimensional and multidimensional; and as disease-centered and patient-centered measures. The creation and validation of scales is complex, with scales undergoing numerous studies to assess criteria such as acceptability, reliability, and responsiveness. In the process of validation of a scale the following attributes should be tested to ascertain whether a scale is an effective instrument of measurement. | ||
| 650 | 7 |
_2embne _9141804 _aParkinson, Enfermedad de |
|
| 700 | 1 |
_aRodríguez Blázquez, Carmen _932500 _0comprobar BNE20011343483 |
|
| 700 | 1 |
_aForjaz, Maria João _988422 |
|
| 700 | 1 |
_aChaudhuri, K. Ray _988423 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-907673-88-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12880966 _b10-10-17 _c11-11-15 |
||
| 942 |
_2lcc _cLE |
||
| 945 |
_aRC382 .M378 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11560782 _z06-04-17 |
||
| 988 | _aEBSPRINGER | ||
| 998 |
_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _gxxk _h0 |
||